pqq cofactor has been researched along with Diabetic Cardiomyopathies in 1 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, XF | 1 |
| Zhai, BZ | 1 |
| Hu, WL | 1 |
| Lou, MH | 1 |
| Chen, YH | 1 |
| Liu, YF | 1 |
| Chen, JG | 1 |
| Mei, S | 1 |
| You, ZQ | 1 |
| Liu, Z | 1 |
| Zhang, LJ | 1 |
| Zhang, YH | 1 |
| Wang, Y | 1 |
1 other study available for pqq cofactor and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Glucose | 2022 |